SCHEMBL6895346

SCHEMBL6895346

CCCCS(=O)(=O)C1CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
LMNA P02545 3/20 0.39
MAPT P10636 2/20 0.39
NPC1 O15118 1/20 0.39
S1PR2 O95136 1/20 0.39
S1PR4 O95977 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
XBP1 P17861 1/20 0.39
S1PR1 P21453 1/20 0.39
MAPK1 P28482 1/20 0.39
AGTR1 P30556 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CTSK P43235 1/20 0.37
FAAH O00519 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20714713 0.91 MMP1 (0.38) ALDH1A1LMNAMAPTNPC1S1PR2
SCHEMBL12735681 0.89 ALDH1A1 (0.33) ALDH1A1LMNAMAPTNPC1S1PR2
SCHEMBL12735659 0.89 CYP1A2 (0.39) ALDH1A1LMNAMAPTNPC1S1PR2
SCHEMBL23149821 0.89 CYP1A2 (0.41) ALDH1A1LMNAMAPTNPC1S1PR2
SCHEMBL12735648 0.84 ALDH1A1 (0.31) ALDH1A1LMNAMAPTNPC1S1PR2
SCHEMBL6893525 0.84
SCHEMBL12735677 0.83 FAAH (0.38) FAAHCA2
SCHEMBL14370975 0.82 FAAH (0.45) FAAHCA2
SCHEMBL20169603 0.81 FAAH (0.43) FAAHCA2
SCHEMBL10904086 0.81 FAAH (0.43) FAAHCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110054013-A1 TETRAHYDROPYRANOCHROMENE GAMMA SECRETASE INHIBITORS MERCK SHARP & DOHME CORP. 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110054013-A1 TETRAHYDROPYRANOCHROMENE GAMMA SECRETASE INHIBITORS BACE1, BACE2, PSEN1 ALDH1A1 1242/4885LMNA 2132/4885MAPT 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.